Arrayit Corp. (ARYC) Sells NanoPrint™ Instrument to Top Canadian Research Center
Life sciences and molecular diagnostics leader Arrayit reports that it has sold a $166,000 NanoPrint™ LM60PRO Enterprise Level Protein Edition Microarray Printer and accessories to a top research center in Ontario, Canada, for use in the manufacture of protein microarrays for interdisciplinary research applications.
Arrayit protein microarrays contain miniaturized collections of intact proteins, the molecules that comprise the building blocks of all living organisms including humans, plants and animals. These protein microarrays provide researchers with the tools necessary to study the structure and function of proteins, which are integral to understanding diverse fundamental research topics such as pharmaceutical compounds, human disease progression, synthetic and stem cell biology, ecology and population genetics.
Arrayit has been selling its patented microarray technology since 1997, and has installed its foundational technology in more than 4,000 laboratories to manufacture an estimated 100 million microarray devices.
The company recently completed a $1 million equity capital raise as well as opened new and expanded Sunnyvale headquarters, which will feature CLIA and ISO laboratories certified with the assistance of DOCRO, an Oxford, Connecticut-based clinical research organization. DOCRO is also assisting the company with its 510(k) submissions to the FDA for OvaDx® and PDx™, the company’s pre-symptomatic diagnostic tests for ovarian cancer and Parkinson’s disease.
For more information, visit www.arrayit.com
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net